Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533851) titled 'A Food Effect Study of VC005 Tablets in Healthy Adult Subjects' on April 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Condition: Atopic Dermatitis

Intervention: Drug: VC005 Tablets

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: April 30, 2026

Target Sample Size: 30

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07533851

Disclaimer: Curated by HT ...